COMMUNIQUÉS West-GlobeNewswire

Route 92 Medical Announces Settlement of Patent Litigation with Q’Apel Medical
06/05/2025
SAN MATEO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced [...]
Moleculin Announces World Health Organization Approval of “naxtarubicin” as International Non-Proprietary Name for Annamycin
06/05/2025
Annamycin has the potential to be safer and more effective than current prescribed anthracyclines to treat serious, hard-to-treat cancers Ongoing pivotal, adaptive Phase 3 clinical trial (the “MIRACLE” trial) evaluating [...]
Earth Science Tech, Inc. Annual Shareholder Letter FY Ending 03/31/2025
06/05/2025
Miami, FL, May 06, 2025 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or “Company”), a strategic holding company, focused on value creation through the acquisition, operational optimization, and [...]
MyoKardia Announces Inaugural MyoSeeds™ Research Grants Program Awardees
07/05/2019
Three Researchers Awarded $250,000 Each to Advance Independent Research in Cardiac Diseases SOUTH SAN FRANCISCO, Calif., May 07, 2019 (GLOBE NEWSWIRE) -- MyoKardia, a clinical-stage biopharmaceutical company pioneering [...]
Imprivata Wins Global InfoSec Awards in Passwordless Authentication and Third Party Risk Categories
06/05/2025
WALTHAM, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Imprivata , the digital identity company for life- and mission-critical industries, today announced that the company has won two Global InfoSec Awards 2025 , presented by [...]
SRx Health Solutions to Host First Quarter 2025 Financial Results Conference Call on May 15th at 4:30 p.m. ET
06/05/2025
TAMPA, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”), a leading global health and wellness company, today announced it will host a conference call and webcast on [...]
Digital Utilities Ventures CEO Mark Gaalswyk Meets with QFFD in Qatar
06/05/2025
Easy Environmental Solutions, Inc. Enters Strategic Talks with QFFD and African Governments to Accelerate a New Era of Regenerative Agriculture and Clean Water Infrastructure Strategic Partnership with QFFD to Transform [...]
CytoDyn Appoints Biotech Veteran Robert E. Hoffman as Chief Financial Officer
06/05/2025
VANCOUVER, Washington, May 06, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple [...]
Alpha Tau to Participate in May Investor Conferences
06/05/2025
JERUSALEM, May 06, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ® , today announced [...]
Viemed Executes Diversification Strategy With $26 Million Acquisition of Home Equipment Provider in Illinois
06/05/2025
LAFAYETTE, La., May 06, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ: VMD), an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the [...]
Achieve Life Sciences to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 13, 2025
06/05/2025
SEATTLE and VANCOUVER, British Columbia, May 06, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV) a late-stage specialty pharmaceutical company focused on the global development and commercialization [...]
Allogene Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update
06/05/2025
Conference Call and Webcast Scheduled for May 13, 2025 at 2:00 p.m. PT/5:00 p.m. ET SOUTH SAN FRANCISCO, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage [...]
Intelligent Bio Solutions Drives Global Growth Through Multilingual Digital Expansion
06/05/2025
Arabic, Italian, and Spanish-language websites unlock commercial access to regions representing over 1.4 billion people Multilingual rollout aligns with product readiness and accelerates international sales pipeline [...]
Palisade Bio Presents Positive Preclinical Data Highlighting Potential of PALI-2108 as a Promising Colon-Specific PDE4 Inhibitor for the Treatment of Ulcerative Colitis and Other Inflammatory Bowel Diseases
06/05/2025
Two posters presented at Digestive Disease Week (DDW) 2025 Preclinical results indicate that PALI-2108 effectively modulates inflammatory pathways in the colon, promoting a favorable immune response Company advancing [...]
Sofwave Medical Reports First Quarter Fiscal 2025 Financial Results and Business Highlights
06/05/2025
— First quarter revenue of $1 6.7 M, +2 6 % year-over-year growth; IFRS gross margin of 7 6.3 % — First quarter pulse recurring revenue of $ 7.0 M , + 49 % year-over-year growth — IFRS and non-IFRS operating loss of -$ [...]
Nova Leap Health Corp. announces Closing of Home Care Acquisition in Nova Scotia
06/05/2025
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, May 06, 2025 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) ("Nova Leap" or “the Company”), a [...]
Windtree Announces Istaroxime Exclusivity and Intellectual Property Potential Strategy for US
06/05/2025
If istaroxime is granted the new chemical entity designation from FDA, it could provide 7.5 years of U.S. exclusivity and additionally the istaroxime U.S. issued method of use patent protects until 2039 for its planned [...]
FOXO TECHNOLOGIES INC.’S BEHAVIORAL HEALTH SUBSIDIARY REACHES KEY OPERATIONAL MILESTONES
06/05/2025
WEST PALM BEACH, FLORIDA, May 06, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “ Company ”) today announced that its behavioral health subsidiary, Myrtle Recovery Centers, Inc., [...]
Candel Therapeutics to Present at Upcoming Investor Conferences
06/05/2025
NEEDHAM, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies [...]

Pages